Coste del cribado del hepatocarcinoma en pacientes cirróticos: un estudio prospectivo

Sort, Pau; Álvarez, Marco Antonio; Bargalló, Anna; Isava, Álvaro; Muñoz, María; Porta, Francesc; Vida, Francesc; Rodríguez, Eva.
Gastroenterol. hepatol. (Ed. impr.) ; 34(8): 519-523, Oct. 2011.
Artículo en Español | IBECS (España) | ID: ibc-94520

Documentos relacionados

  1. Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
  2. Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis.
  3. Current situation of viral hepatitis in Egypt.
  4. Global Epidemiology and Genetics of Hepatocellular Carcinoma.
  5. Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
  6. Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study.
  7. Hepatocellular carcinoma (HCC) is changing its face: analysis of the temporal trends in aetiology and clinical patterns of HCC in South Australia.
  8. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference.
  9. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma.
  10. Outcome of Hepatocellular Carcinoma Detected During Surveillance: Comparing USA and Japan.